ozempic
Novo Nordisk Q3 Sales Surge on GLP-1 Meds Amid Manufacturing Queries
Since the FDA gave the green light to Novo Nordisk’s GLP-1 weight-loss medication Wegovy over two years ago, the drug ...
Fake Ozempic products seized in EU and UK, Novo Nordisk warns
As Novo Nordisk grapples with the challenges posed by illicit sales of semaglutide, authorities in the UK and Europe have ...
Novo Nordisk raises its 2023 outlook for sales and profit, driven by strong diabetes and obesity drugs
Novo Nordisk is experiencing a remarkable surge in its fortunes, primarily driven by the widespread popularity of its diabetes medication ...
Novo’s Ozempic shows promise in kidney disease, but DaVita questions its real-world benefits
Novo Nordisk’s GLP-1 blockbuster Ozempic appears to be making significant strides in the treatment of chronic kidney disease (CKD), potentially ...
Semaglutide’s Remarkable Success in Kidney Disease Trial Prompts Early Completion
In a recent development surrounding the study of injectable semaglutide’s efficacy in chronic kidney disease, Novo Nordisk has found reason ...
Viatris challenges Novo Nordisk’s patent on diabetes drug semaglutide
In Viatris’ ambitious bid to be the first to introduce generic versions of Novo Nordisk’s blockbuster diabetes and obesity drugs, ...
Eli Lilly Sues 8 Companies for selling fake Mounjaro versions
The surging demand for GLP-1 diabetes and weight loss medications has led to an inevitable influx of knockoff versions. Earlier ...
Novo Nordisk Turns to Thermo Fisher for Production Aid with Obesity Drug Wegovy Amid Catalent Challenges
Novo Nordisk Struggles to Keep Up with High Demand for Wegovy, Enlists Thermo Fisher to Boost Production Amid soaring demand ...
Novo Nordisk and Eli Lilly Ride Obesity and Diabetes Drugs to the Forefront in Q2 Pharmaceutical Performance
As the COVID-19 pandemic surged and waned, the biopharmaceutical industry witnessed a rollercoaster ride of revenue spikes and troughs. However, ...
Weighing the benefits and drawbacks of the newest Weight loss medication as well as their financial impact
Weight Loss Medication: Obesity rates in the United States have significantly increased since the 1980s, with a staggering 41.9% of ...
GLP-1 medications from Novo Nordisk are being examined in Europe following reports suggest potential suicide risks
Following reports of two cases of suicidal thoughts and one case of self-harm among users in Iceland, the European Medicines ...
New lawsuits from Novo Nordisk are filed against synthetic versions of Wegovy and Ozempic
Source – FDA The increasing demand for GLP-1 drugs, which can lead to significant weight loss, has resulted in unauthorized ...
Novo Nordisk plans to stop compounded versions of Ozempic and Wegovy with fresh litigation
Source – Fierce Pharma Novo allegedly filed separate lawsuits against health spas, clinics, and pharmacies in Florida, New York, Tennessee, ...
